- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03115372
Lay Health Worker Outreach in Increasing Colorectal Cancer Screening in Asian Americans
The National Center for Reducing Asian American Cancer Health Disparities Research Project on Lay Health Workers and Asian Americans (AANCART)
Studieoversikt
Status
Detaljert beskrivelse
PRIMARY OBJECTIVES:
I. Evaluate the efficacy of lay health worker (LHWs) outreach on colorectal cancer (CRC) screening among 3 Asian American groups (Filipinos, Hmong, and Koreans) in a cluster randomized controlled trial (RCT) comparing CRC education delivered by LHWs (intervention) to a CRC brochure and nutrition education (control).
II. Examine the processes through which LHWs communicate with, connect to, and convince community members from 3 Asian American cultures of the importance of CRC screening using mixed methods.
OUTLINE: Lay health workers (LHWs) are randomized to 1 of 2 groups.
GROUP I (CRC EDUCATION): LHWs undergo training over 3 days and recruit 15 participants from their social network. Participants attend a CRC educational session conducted by an LHW over 90 minutes at month 1 and 3. Participants receive phone calls from the LHW at months 2 and 4 reminding them about CRC screening.
GROUP II (CRC BROCHURE): LHWs undergo training over 3 days and recruit 15 participants from their social network. Participants attend a lecture on healthy nutrition for cardiovascular health presented by a professional health educator at months 1 and 3. After the first meeting, participants receive a brochure on CRC screening. Participants receive phone calls from the LHW at months 2 and 4 regarding changes in their nutritional behavior. Participants may attend an optional post-intervention LHW outreach session on CRC screening.
After completion of the study, patients are followed up at 2 months.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
California
-
Los Angeles, California, Forente stater, 90095
- UCLA / Jonsson Comprehensive Cancer Center
-
Sacramento, California, Forente stater, 95817
- University of California Davis Comprehensive Cancer Center
-
San Francisco, California, Forente stater, 94115
- University of California, San Francisco
-
-
Hawaii
-
Honolulu, Hawaii, Forente stater, 96813
- University of Hawaii Cancer Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- LHW: self-identified as Filipino, Hmong, or Korean Americans
- LHW: age 18 or older
- LHW: are fluent in a Filipino language (Tagalog or Ilocano), Hmong, Korean, or English
- LHW: Live in the relevant area and intend to stay there for the next 12 months
- PARTICIPANTS: Self-identified as Filipino, Hmong, or Korean Americans
- PARTICIPANTS: speak a language that the LHW can speak such as Tagalog, Ilocano, Hmong, Korean, or English
- PARTICIPANTS: live in relevant area and intend to stay there for at least 12 months
- PARTICIPANTS: Are willing to participate in a study about health behaviors involving nutrition or CRC screening
Exclusion Criteria:
- Personal history of CRC
- Medical problems which may prevent them from attending 2 educational sessions
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Group I (CRC education)
LHWs undergo training over 3 days and recruit 15 participants from their social network.
Participants attend a CRC educational session conducted by an LHW over 90 minutes at month 1 and 3. Participants receive phone calls from the LHW at months 2 and 4 reminding them about CRC screening.
|
Hjelpestudier
Attend CRC education session
Andre navn:
Attend healthy nutrition session
Andre navn:
Receive telephone reminder about CRC screening
Receive telephone reminder about healthy nutrition
|
|
Aktiv komparator: Group II (CRC brochure)
LHWs undergo training over 3 days and recruit 15 participants from their social network.
Participants attend a lecture on healthy nutrition for cardiovascular health presented by a professional health educator at months 1 and 3.
After the first meeting, participants receive a brochure on CRC screening.
Participants receive phone calls from the LHW at months 2 and 4 regarding changes in their nutritional behavior.
Participants may attend an optional post-intervention LHW outreach session on CRC screening.
|
Hjelpestudier
Attend CRC education session
Andre navn:
Attend healthy nutrition session
Andre navn:
Receive telephone reminder about CRC screening
Receive telephone reminder about healthy nutrition
Receive CRC screening brochure
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of participants who report ever having had a CRC screening test
Tidsramme: Baseline to 6 months
|
Bivariable and multivariable analyses of the binary outcomes (CRC screening ever, up-to-date, and intention) will be conducted using generalized linear models to evaluate the efficacy of the intervention.
A linear model with identity link function will be used with group (intervention or control), time (pre- or post-), and group-by-time interaction to test for a difference in the change from pre- to post-intervention between the 2 groups, thus measuring the efficacy of the intervention.
|
Baseline to 6 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of participants who are up-to-date for CRC screening
Tidsramme: At 6 months
|
Bivariable and multivariable analyses of the binary outcomes (CRC screening ever, up-to-date, and intention) will be conducted using generalized linear models to evaluate the efficacy of the intervention.
|
At 6 months
|
|
Proportion of participants who intend to obtain CRC screening in the next 6 months
Tidsramme: At 6 months
|
Bivariable and multivariable analyses of the binary outcomes (CRC screening ever, up-to-date, and intention) will be conducted using generalized linear models to evaluate the efficacy of the intervention.
|
At 6 months
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Tung Nguyen, University of California, San Francisco
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 11056 (DAIDS ES Registry Number)
- U54CA153499 (U.S. NIH-stipend/kontrakt)
- NCI-2017-00515 (Registeridentifikator: CTRP (Clinical Trial Reporting Program))
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Kolorektal karsinom
-
Tongji HospitalHar ikke rekruttert ennåMuskelinvasiv Blæreurotelial Carcinom
-
Stingray TherapeuticsRekrutteringRefractory Metastatic Microsatelite Stabil Colorectal Cancer (MSS-CRC)Forente stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)FullførtMetastatisk kolorektalt karsinom | Trinn IV tykktarmskreft AJCC v8 | Stage IVA tykktarmskreft AJCC v8 | Stage IVB tykktarmskreft AJCC v8 | Stage IVC Colorectal Cancer AJCC v8Forente stater
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)FullførtTrinn IV tykktarmskreft AJCC v7 | Stage IVA kolorektal kreft AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Kolorektalt adenokarsinom | RAS Wild TypeForente stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)Har ikke rekruttert ennåMetastatisk kolorektalt karsinom | Stage IVC Colorectal Cancer AJCC v8 | Ikke-opererbart kolorektalt karsinom | Metastatisk appendix karsinom | Metastatisk malign neoplasma i bukhinnen | Stage IV vedlegg Karsinom AJCC v8Forente stater
-
Ning JinFullførtMetastatisk kolorektalt karsinom | Trinn IV tykktarmskreft AJCC v8 | Stage IVA tykktarmskreft AJCC v8 | Stage IVB tykktarmskreft AJCC v8 | Stage IVC Colorectal Cancer AJCC v8Forente stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)FullførtTrinn IV tykktarmskreft AJCC v7 | Stage IVA kolorektal kreft AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Metastatisk karsinom i leveren | Resektabel masseForente stater
-
M.D. Anderson Cancer CenterRekrutteringMetastatisk malign neoplasma i leveren | Metastatisk kolorektalt karsinom | Trinn IV tykktarmskreft AJCC v8 | Stage IVA tykktarmskreft AJCC v8 | Stage IVB tykktarmskreft AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Resektabelt kolorektalt karsinomForente stater
-
University of California, San FranciscoMerck Sharp & Dohme LLCFullførtTrinn IV tykktarmskreft AJCC v7 | Stage IVA kolorektal kreft AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Mikrosatellitt stabil | Trinn III tykktarmskreft AJCC v7 | Trinn IIIB tykktarmskreft AJCC v7 | Stage IIIC tykktarmskreft AJCC v7 | Mismatch Repair Protein dyktigForente stater
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)FullførtTrinn IV tykktarmskreft AJCC v7 | Stage IVA kolorektal kreft AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Tilbakevendende kolorektalt karsinom | Metastatisk karsinom i leverenForente stater
Kliniske studier på Undersøkelsesadministrasjon
-
Yale UniversityNational Institute on Drug Abuse (NIDA); APT Foundation, Inc.FullførtTobakksbruk | Sigarett røykingForente stater
-
Pennington Biomedical Research CenterMartin, Corby, K., M.D.FullførtErnæringsvitenskap | Klima | Resirkulering | AvfallshåndteringForente stater
-
Abramson Cancer Center at Penn MedicineConquer Cancer FoundationFullførtMage-tarmkreft | LungekreftForente stater
-
Medipol UniversityFullførtSlag | Bevisbasert praksis | FysioterapeutTyrkia (Türkiye)
-
University of NottinghamKing's College London; National Institute for Health Research, United KingdomRekrutteringFibrose | Artroplastikkkomplikasjoner | Kontraktur av kneleddStorbritannia
-
Children's Mercy Hospital Kansas CityRekrutteringImplementering av Spotlight AQ-plattformen hos ungdom/ung voksen (16–25 år) Type 1-diabetikere (T1D)Type 1 diabetes mellitusForente stater
-
Boston Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Fullført
-
Henry Ford Health SystemRekrutteringFor tidlig fødsel | Cervikal insuffisiens | Cervikal lengdemålingForente stater
-
Ceribell Inc.FullførtAnfall | Ikke-konvulsiv Status EpilepticusForente stater
-
Abramson Cancer Center at Penn MedicinePåmelding etter invitasjon